Rani Therapeutics Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$33,970,000 over the previous period. Total operating expenses were $66,099,000.
Profit Margin
| 2019 | 979K | -26.59M | -2716.75% |
|---|---|---|---|
| 2020 | 462K | -16.70M | -3615.37% |
| 2021 | 2.71M | -53.08M | -1953.92% |
| 2022 | 0 | -63.34M | |
| 2023 | 0 | -33.97M |
RANI Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 2.71M | 462K | 979K |
Cost of revenue | 822K | 1.31M | 0 | 0 | 0 |
Gross profit | -822K | -1.31M | 2.71M | 462K | 979K |
Operating exp. | |||||
Research and development | 39.62M | 36.60M | 26.48M | 12.04M | 24.57M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 66.09M | 63.45M | 54.31M | 17.00M | 28.04M |
Operating income | -66.09M | -63.45M | -51.59M | -16.54M | -27.06M |
Other income (expenses), net | -1.78M | 177K | -1.44M | -124K | 478K |
Income before tax | -67.88M | -63.27M | -53.04M | -16.66M | -26.58M |
Income tax expense | 0 | 70K | 41K | 35K | 10K |
Net income | -33.97M | -63.34M | -53.08M | -16.70M | -26.59M |
Earnings per share | |||||
Basic EPS | -1.33 | -2.66 | -2.69 | -0.85 | -1.35 |
Diluted EPS | -1.33 | -2.66 | -2.69 | -0.85 | -1.35 |
| Data source | Data source | Data source |